Skip to main content
. 2021 Aug 19;8:718184. doi: 10.3389/fsurg.2021.718184

Figure 2.

Figure 2

(A) Chemotherapy treatment according to NB2004 protocols. Middle line - median; Interquartile range - box; 25–75% - Whiskers; Tukey Test. (B) Distribution of the tPMA z-score at L4-5 among survival groups within the NB2004 high-risk group. Middle line - mean; Upper and lower lines - SD. (C) Prevalence of sarcopenia among survival groups within the NB2004 high-risk group. Chemo, chemotherapy; MRG, medium risk group; HRG, high-risk group; DOD, death of disease.